Dun Liang

Company: Loxo@Lilly

Job title: Executive Director, Regulatory Affairs, CDx

Seminars:

Piloting Change: The FDA’s Bold Strategies to Reduce the Burden in Clinical Trials 3:00 pm

Delving into the specifics of the FDA’s Oncology Diagnostic (Dx) Pilot Program and outlining the broader objectives of this initiative Comparing the new pilot to the current CDx regulations, while also discussing the potential challenges associated with industry participation and the practical aspects of implementing these policies Investigating the likely influence of this program on…Read more

day: day 2